RETINA

Welcome to the Brand page for “RETINA”, which is offered here for Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, molecular diagnostic kits used to generate a clinical or scientific result by amplification and / or detection of dna or rna sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of hiv and other virus detection, mitochondrical function and / or toxicity, and for tumor markers; medical diagnostic reagents; kits for dna and rna analysis comprised primarily of chemical reagents for clinical or medical laboratory use, all specifically in the field of hiv and other virus detection, mitochondrical function and/or toxicity and for tumor markers;diagnostic preparations and reagents for scientific or research use; chemical and biochemical reagents for scientific rna and dna research use; kits for dna and rna analysis comprised primarily of chemical reagents for scientific or research use, all specifically in the field of hiv and other virus detection, mitochondrical function and/or toxicity and for tumor markers;medical and veterinary diagnostic apparatus and instruments to be used with molecular diagnostic kits used to generate a clinical or scientific result by amplification and/or detection of dna or rna sequences in tissues, body fluids and / or cells of human or animal origin, specifically in the field of hiv and other virus detection, mitochondrical function and / or toxicity, and for tumor markers;.

Its status is currently believed to be active. Its class is unavailable. “RETINA” is believed to be currently owned by “PrimaGen Holding B.V.”